Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when IART files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsIntegra LifeSciences cuts FY26 guidance after Cincinnati flooding; Q3 revenue seen at $410-412M
Filed October 2, 2026 · Period ending October 2, 2026 · ~1 min read
Key Changes
-
high
FY2026 revenue guidance lowered to $1.634B-$1.654B from $1.654B-$1.695B, a $20M midpoint cut.
Item 7.01 verify on EDGAR → -
high
FY2026 adjusted EPS guidance reduced to $2.30-$2.40 from $2.40-$2.50.
Item 7.01 verify on EDGAR → -
high
Flooding at the Cincinnati facility cut Q3 revenue by ~$7M and is expected to reduce Q4 revenue by $15M-$20M; full operations not expected until Q2 2027.
Item 7.01 verify on EDGAR → -
medium
Operating cash flow guidance maintained: >$85M in Q3 and $190M-$200M for FY2026.
Item 7.01 verify on EDGAR →
Summary
Integra LifeSciences preannounced third-quarter results and cut full-year guidance, citing the July flooding at its Cincinnati manufacturing facility. The company expects Q3 revenue of $410 million to $412 million and adjusted EPS of $0.55 to $0.59. For the full year, revenue guidance was lowered by $20 million at the midpoint to $1.634 billion to $1.654 billion, and adjusted EPS guidance was reduced by $0.10 to $2.30 to $2.40.
The flooding is estimated to have reduced Q3 revenue by about $7 million and is expected to cut Q4 revenue by $15 million to $20 million, with full manufacturing operations not resuming until the second quarter of 2027. Despite the disruption, the company maintained its operating cash flow outlook of over $85 million for Q3 and $190 million to $200 million for the year. The filing is a routine pre-earnings disclosure under Regulation FD and Item 2.02, with no red flags identified.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Integra LifeSciences announced preliminary Q3 2026 results and a Cincinnati facility update via press release.
Added in current filing · verify on EDGAR →
On October 2, 2026, the Company issued a press release that announced certain preliminary unaudited results for the third quarter ended September 30, 2026 and provided an update on the Company’s Cincinnati facility.
The company issued a press release disclosing preliminary unaudited third-quarter results and an update on its Cincinnati facility. The press release is attached as Exhibit 99.1. The filing does not include the actual figures in the body of the 8-K; they are in the exhibit.
Event · Exhibit 99.1
Integra preannounces Q3 2026 revenue of ~$410-412M and cuts FY26 guidance due to July Cincinnati facility flooding.
Added in current filing · view on EDGAR →
The Company is updating its adjusted earnings per diluted share guidance from a range of $2.40 to $2.50 to a range of $2.30 to $2.40
Adjusted EPS guidance for full-year 2026 was reduced by $0.10 at both the low and high ends, to $2.30 to $2.40 from $2.40 to $2.50. The reduction reflects the expected earnings impact of the Cincinnati facility flooding and updated business assumptions.
Event · Item 2.02 — Results of Operations and Financial Condition
Integra LifeSciences preannounces Q3 2026 revenue of $410-412M, adjusted EPS of $0.55-0.59, and operating cash flow above $85M.
Added in current filing · verify on EDGAR →
The Company expects its reported revenue to be between $410 million to $412 million, reflecting an estimated $7 million impact of flooding-related supply disruptions on the Company’s manufacturing facility in Cincinnati, Ohio (the “Cincinnati facility”).
Integra disclosed preliminary third-quarter revenue guidance of $410 million to $412 million. The company attributes an estimated $7 million negative impact to flooding-related supply disruptions at its Cincinnati manufacturing facility.
Added in current filing · verify on EDGAR →
In addition, the Company expects operating cashflow to be greater than $85 million in the third quarter.
Integra expects third-quarter operating cash flow to exceed $85 million, indicating healthy cash generation despite the supply disruption.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Oct 5, 2026 · How we verify